Cite
HARVARD Citation
Kussmann, M. et al. (2018). Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis. Emerging microbes & infections. 7 (1), pp. 1-10. [Online].